Huntington’s disease genetic testing is a blood test that counts how often a three-letter piece of DNA, CAG, repeats in your HTT gene. People with 40 or more repeats almost always develop the disorder, 36 to 39 may or may not, and 27 to 35 does not cause it but can put a child at risk.
When a parent has HD, each child has a 50% chance of inheriting the genetic variant, which is why most people look this test up. The answer comes from a clinical test that counts the repeats, usually arranged with a genetic counselor. A home DNA kit is not the place to look, for reasons explained below.
What does a Huntington’s genetic test measure?
It measures one stretch of one gene. The most accurate way to test for HD is to count the number of CAG repeats in the HTT gene, using DNA from a blood sample. Normally, the CAG segment is repeated 10 to 35 times; in people with Huntington’s disease it is repeated 36 to more than 120 times.
Huntington’s is inherited in an autosomal dominant pattern, which means one altered copy of the gene is enough to cause the disorder. The same test is used in two ways: to confirm or rule out the disease in someone with symptoms, and to tell someone without symptoms their chance of developing or passing it on.
Huntington’s is unusual among gene questions because a single gene decides it. For a gene question where the evidence is much weaker, see our article on MTHFR gene mutation symptoms.
What do the results mean?
The number of repeats places the result in one of a few bands. The table below uses the ranges published by MedlinePlus Genetics, the National Library of Medicine’s genetics reference.
| CAG repeats | What it means |
|---|---|
| 10 to 35 | The usual range. Huntington’s disease is linked to 36 or more repeats. |
| 27 to 35 | You do not develop the disease, but the count can grow when passed on, so a child may be at risk. |
| 36 to 39 | You may or may not develop signs and symptoms. |
| 40 or more | You will almost always develop the disease. |
| More than 60 | Typical of the juvenile form, which begins in childhood or adolescence. |
The lab part is very reliable: Cleveland Clinic puts the test’s accuracy at 99.9%. The hard part is the middle bands. With 36 to 39 repeats, nobody can say for sure whether symptoms will come.
Why can the count grow from parent to child?
Because the repeat is unstable. As the altered gene is passed from one generation to the next, the size of the CAG repeat often increases, and a larger number of repeats is usually linked to earlier symptoms. Doctors call this anticipation.
Cleveland Clinic notes that this growth happens especially in men, because the repeat size sometimes gets larger when sperm is created. That is why a result of 27 to 35 matters for family planning, even though it does not cause the disease in the person who carries it.
Can a home DNA test or raw DNA file show Huntington’s?
Do not count on it. 23andMe says the genotyping platform it uses is not capable of detecting trinucleotide repeats, so it has no reports on these disorders, and its raw data holds nothing relevant to them either. It names Huntington’s disease as one of those disorders.
A home DNA file that says nothing about Huntington’s does not mean you are clear.
Whole-genome sequencing reads far more of your DNA, but long repeats are still hard for it. Researchers describe identifying large repeat expansions as challenging for short-read whole-genome data, and built special software to do it. In a test set that included Huntington’s disease, that software flagged all but one of the known expansions.
That is promising for research, but it is not a clinical result. For a real answer, the National Institute of Neurological Disorders and Stroke describes counting the CAG repeats in DNA from a blood sample as the most accurate way to test.
Why can the same count mean a different age of onset?
Because the count is the main factor, not the only one. Adult-onset Huntington’s disease usually appears in a person’s thirties or forties, and more repeats usually mean earlier symptoms.
A 2019 study by the Genetic Modifiers of Huntington’s Disease consortium found that the timing of onset is influenced by variation in several DNA maintenance genes. It also found that the length of the uninterrupted CAG stretch, rather than the length of the protein segment it codes for, sets how fast the disease develops.
The repeat can also change inside the body. In some people with HD, the number of CAG repeats increases over time, which may contribute to symptoms starting earlier and worsening faster. Researchers are still studying how the repeat changes over a lifetime, so this helps explain different timelines rather than predict one.
How does testing work if you have no symptoms?
It usually starts with a genetic counselor, not a lab order. Cleveland Clinic describes meeting with a genetics counselor as part of the process. It also says that if you are under 18, you have to show symptoms of Huntington’s disease before you can get tested.
There is a reason for the care. There is no treatment that can stop or reverse HD, but some of the symptoms can be treated. Some people would rather not live with that knowledge. A negative result can bring its own kind of stress too, especially for people who have lost family members to the disease.
Stopping partway is not unusual. A Western Australian predictive testing centre reviewed 518 people who applied for testing, most of them at risk of Huntington’s. In that program, 13% of applicants withdrew, and about 80% of those withdrawals happened during the counselling stages.
What about insurance and having children?
Know the insurance rules before you test. In the US, the Genetic Information Nondiscrimination Act (GINA) protects you from genetic discrimination in health insurance and employment. GINA’s health insurance protections do not cover long-term care, life or disability insurance. It also does not apply to employers with fewer than 15 employees.
Some states have their own laws that reach those other kinds of insurance, so check the rules where you live.
For family planning, prenatal testing is an option for people who have a family history of Huntington’s. Pre-implantation genetic testing is another, for people who go through in vitro fertilization: embryos are tested in the lab before they are implanted.
What you might try (talk to your doctor first)
- Start with a genetic counselor. Ask your doctor for a referral, and go through what each result band would mean for you before you decide.
- Look at your insurance first. Because GINA does not cover life, disability or long-term care insurance, review those policies before you have the test.
- Do not use a raw DNA file as your answer. Silence about Huntington’s in a home DNA file tells you nothing either way.
- Ask what support comes with the result. If a result is positive, Cleveland Clinic notes that a mental health professional can help you adjust.
- If you are planning a pregnancy, say so early. Ask about prenatal testing and pre-implantation testing with in vitro fertilization.
How Enovone can help
Ena, Enovone’s AI health guide, can read a DNA report or raw file you already have and tell you plainly what it covers and what it cannot, including whether it says anything about HTT at all. Ena can also help you write down questions to bring to a genetic counselor. You can read more about how Enovone reads DNA.
A licensed clinician makes every medical decision. For Huntington’s, the right next step is a clinical test with counseling, not an app. Ask Ena what your DNA file can and cannot tell you.
Common questions
How accurate is the Huntington’s disease genetic test?
Very accurate: Cleveland Clinic puts its accuracy at 99.9%. What it cannot always settle is the meaning of a middle result. With 36 to 39 repeats a person may or may not develop symptoms, and with 27 to 35 the person does not develop the disease but a child may. A genetic counselor can explain where your number sits.
Can you get tested for Huntington’s disease under 18?
Usually only if there are symptoms. According to Cleveland Clinic, if you are under 18 you have to show symptoms of Huntington’s disease before you can get tested. Adults without symptoms can choose predictive testing, which usually starts with a genetic counselor rather than a lab order.
Does 23andMe test for Huntington’s disease?
No. 23andMe says the genotyping platform it uses is not capable of detecting trinucleotide repeats, so it has no reports on these disorders, and its raw data holds nothing relevant to them either. Huntington’s is caused by an expanded CAG repeat, so a clinical test that counts the repeats is the way to find out.
If I test positive, can the test tell me when symptoms will start?
Not exactly. More repeats usually mean earlier symptoms, and adult-onset Huntington’s usually appears in a person’s thirties or forties. But research shows variation in DNA maintenance genes also shifts the timing, and in some people the repeat grows inside the body over time. So two people with the same number can have different timelines.
Can a Huntington’s test result affect my insurance?
In the US, GINA protects you from genetic discrimination in health insurance and employment. It does not cover life, disability or long-term care insurance, and it does not apply to employers with fewer than 15 employees. Some states add their own protections, so check your state’s rules and your policies before you test.
Sources
- MedlinePlus Genetics (U.S. National Library of Medicine). Huntington’s disease.
- National Institute of Neurological Disorders and Stroke. Huntington’s Disease.
- Cleveland Clinic. Should You Get Genetic Testing for Huntington’s Disease?
- 23andMe Support. Conditions Not Included in 23andMe.
- Dolzhenko E, et al. Detection of long repeat expansions from PCR-free whole-genome sequence data. Genome Research, 2017.
- Genetic Modifiers of Huntington’s Disease (GeM-HD) Consortium. CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset. Cell, 2019.
- Predictive gene testing for Huntington disease and other neurodegenerative disorders. Internal Medicine Journal, 2013.
- National Human Genome Research Institute. Genetic Discrimination.